Literature DB >> 32913212

Clinical trial recovery from COVID-19 disruption.

John Z Xue, Katarzyna Smietana, Pawel Poda, Kevin Webster, Guang Yang, Gaurav Agrawal.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32913212     DOI： 10.1038/d41573-020-00150-9

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  15 in total

1.  Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP).

Authors:  Ashish Sarraju; Clark Seninger; Vijaya Parameswaran; Christina Petlura; Tamara Bazouzi; Kiranbir Josan; Upinder Grewal; Thomas Viethen; Hardi Mundl; Joachim Luithle; Leonard Basobas; Alexis Touros; Michael J T Senior; Koen De Lombaert; Kenneth W Mahaffey; Mintu P Turakhia; Rajesh Dash
Journal:  NPJ Digit Med       Date:  2022-06-28

Review 2.  A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety Challenges.

Authors:  Daniel Eisenman; Shaun Debold; James Riddle
Journal:  Appl Biosaf       Date:  2021-11-24

3.  Assessing the impact of COVID-19 on registered interventional clinical trials.

Authors:  Nour Hawila; Arthur Berg
Journal:  Clin Transl Sci       Date:  2021-05-08       Impact factor: 4.689

4.  The Impact of COVID-19 on the Initiation of Clinical Trials in Europe and the United States.

Authors:  Florian Lasch; Eftychia-Eirini Psarelli; Ralf Herold; Andrea Mattsson; Lorenzo Guizzaro; Frank Pétavy; Anja Schiel
Journal:  Clin Pharmacol Ther       Date:  2022-02-17       Impact factor: 6.903

5.  COVID-19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union.

Authors:  Amos Jochanan de Jong; Yared Santa-Ana-Tellez; Ghislaine José Madeleine Wilhelmien van Thiel; Mira Gerta Petra Zuidgeest; Satu Johanna Siiskonen; Dinesh Mistry; Anthonius de Boer; Helga Gardarsdottir
Journal:  Clin Pharmacol Ther       Date:  2021-04-02       Impact factor: 6.903

Review 6.  Mental Health Clinical Research Innovations during the COVID-19 Pandemic: The Future Is Now.

Authors:  Kelly B Ahern; Eric J Lenze
Journal:  Psychiatr Clin North Am       Date:  2021-11-12

7.  Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences?

Authors:  Kevin Klein; Pieter Stolk; Pär Tellner; Virginia Acha; Sarah Montagne; Isabelle Stöckert
Journal:  Ther Innov Regul Sci       Date:  2022-02-07       Impact factor: 1.337

8.  The impact of the COVID-19 pandemic on scientific research in the life sciences.

Authors:  Massimo Riccaboni; Luca Verginer
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

9.  Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic.

Authors:  Arnaud Bayle; Capucine Baldini; Patricia Martin-Romano; Jean-Marie Michot; Stéphane Champiat; Rastilav Bahleda; Anas Gazzah; Aurélien Marabelle; Loic Verlingue; Arthur Geraud; Daphné Morel; Stefan Michiels; Antoine Hollebecque; Laurence Albiges; Benjamin Besse; Jean-Charles Soria; Christophe Massard; Fabrice Barlesi; Sophie Postel-Vinay
Journal:  Cancer Cell       Date:  2021-06-18       Impact factor: 38.585

10.  Lessons Learned Recruiting and Retaining Pregnant and Postpartum Individuals in Digital Trials: Viewpoint.

Authors:  Amanda M Parks; Jennifer Duffecy; Jennifer E McCabe; Rachel Blankstein Breman; Jeannette Milgrom; Yafit Hirshler; Alan W Gemmill; Lisa S Segre; Jennifer N Felder; Lori Uscher-Pines
Journal:  JMIR Pediatr Parent       Date:  2022-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.